Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Selective hepatitis A vaccination “economically worthwhile” in Italy

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Selective hepatitis A vaccination “economically worthwhile” in Italy. Pharmacoecon. Outcomes News 417, 10 (2003). https://doi.org/10.1007/BF03276416

    Download citation

    Keywords

    • Outcome News
    • Measle
    • Rubella
    • Mumps
    • Vaccination Strategy